Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world to answer the globes growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry to respond to these challenges by designing and building new organisms and sequencing the natural world. Today, our foundry is deeply engaged in responding to the COVID-19 pandemic by developing sequencing-based diagnostics and collaborating with vaccine developers. We are also developing organisms to make products across multiple industries.
Were looking for an Intellectual Property (IP) Counsel with a deep understanding of life sciences, patent prosecution, intellectual property transactions and licensing, and strategic patent issues. Reporting directly to our Head of IP, you will work on licensing issues associated with Ginkgos collaboration transactions, freedom-to-operate analyses, patent prosecution, and other intellectual property matters. This role will be critical to ensuring that Ginkgos inventions can be successfully partnered, commercialized, and protected.
– For this position, we are looking for applicants who have five or more years of experience. For applicants who have ten or more years of experience, we will consider them for a Senior IP Counsel role.
– As part of the application process, applicants will be asked to return a brief patent prosecution exercise.
To learn more about Ginkgo, check out some recent press:
Ginkgo Bioworks Awarded $40MM NIH RADx-ATP Contract to Expand High Throughput SARS-CoV-2 Testing (PR Newswire)
Ginkgo Bioworks CEO on scaling up Covid-19 testing: If we try, we can win(CNBC)
Ginkgo raises $70 million to ramp up COVID-19 testing for employers, universities (Boston Globe)
Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)
Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response (PRNewswire)
The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)
Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)
Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)
Can This Company Convince You to Love GMOs? (The Atlantic)
We also feel its important to point out the obvious here theres a serious lack of diversity in our industry and it needs to change. Our goal is to help drive that change. Ginkgo is deeply committed to diversity, equality, and inclusion in all of its practices, especially when it comes to growing our team. We hope to continue to build a company whose culture promotes inclusion and embraces how rewarding it is to work with engineers from all walks of life. Making biology easier to engineer is a tough nut to crack we cant afford to leave any talent untapped.
It is the policy of Ginkgo Bioworks to provide equal employment opportunities to all employees and employment applicants.